Search

for
Search:

Sort by

Research

990-1000 / 1000+ results

research Efficacy of a Complex of 5-Aminolevulinic Acid and Glycyl-Histidyl-Lysine Peptide on Hair Growth

8 citations , January 2016 in “Annals of Dermatology”

A complex of 5-aminolevulinic acid and glycyl-histidyl-lysine peptide may help increase hair count in male pattern hair loss without side effects.

research Effects of In Utero Exposure to D-004, a Lipid Extract from Roystonea regia Fruits, in the Male Rat: A Comparison with Finasteride

8 citations , August 2011 in “Journal of Medicinal Food”

D-004 may be a natural alternative to finasteride for treating enlarged prostate and male baldness.

research The shifting preferences of patients and physicians in nonsurgical hair loss treatment

7 citations , September 2020 in “Journal of Cosmetic Dermatology”

Minoxidil and Finasteride are the most popular hair loss treatments, with rising interest in other options, and economic or health crises can change what treatments people prefer.

research Post-finasteride syndrome – does it really exist?

7 citations , January 2019 in “The Aging Male”

Post-finasteride syndrome's existence is uncertain; more research needed.

research COVID‐19, androgens, and androgenic alopecia

6 citations , December 2020 in “Dermatological reviews”

COVID-19 may worsen with androgens; anti-androgen drugs could help.

Male Balding as a Major Risk Factor for Severe COVID-19: A Possible Role for Targeting Androgens and Transmembrane Protease Serine 2 to Protect Vulnerable Individuals

research Male balding as a major risk factor for severe COVID-19: A possible role for targeting androgens and transmembrane protease serine 2 to protect vulnerable individuals

6 citations , September 2020 in “Journal of The American Academy of Dermatology”

Severe male balding may increase the risk of serious COVID-19, and treatments that reduce androgens or block a specific enzyme might help protect these individuals.

Risk of Rhabdomyolysis from 5-Alpha Reductase Inhibitors

research Risk of rhabdomyolysis from 5-α reductase inhibitors

6 citations , January 2018 in “Pharmacoepidemiology and Drug Safety”

Starting 5-alpha reductase inhibitors does not significantly increase the risk of rhabdomyolysis in older men, but is linked to a higher risk of muscle conditions.

research Systemic dexpanthenol as a novel treatment for female pattern hair loss

5 citations , September 2020 in “Journal of Cosmetic Dermatology”

Dexpanthenol improves hair growth and satisfaction in women without side effects.

research Female pattern hair loss in men: A distinct clinical variant of androgenetic alopecia

5 citations , September 2020 in “Journal of The American Academy of Dermatology”

Men can experience female pattern hair loss, needing different treatments.

research Clascoterone as a novel treatment for androgenetic alopecia

5 citations , May 2020 in “Clinical and Experimental Dermatology”

Clascoterone may be a promising treatment for hair loss.

← Previous page